Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma, Transitional Cell × Radium-223 × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

Fluorodeoxyglucose F18 2 fluciclovine F-18 1 atezolizumab 1 X-Rays 1 Radium-223 1 RXDX-106 1 Positron Emission Tomography Computed Tomography 1 Magnetic Resonance Spectroscopy 1 Aminophylline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03208712 2018-10-24

Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Terminated

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡